2m 2m 2m 2m 2m 2m 2m
Tevogen (TVGN)
NASDAQ
$5.48-$0.52 (-8.67%)
Price as of Nov 12, 2026 4:00 AM EST- $100.6MMarket Cap
- -74.23%1-Year Change
- BiotechnologyIndustry
Tevogen (TVGN)
$5.48-$0.52 (-8.67%)
TVGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.00 | ||
Change | +$0.28 (+4.90%) | ||
Open | $5.98 | ||
High | $6.00 | ||
Low | $5.91 | ||
Previous Close | $5.72 | ||
Volume | 3,134 | ||
30-Day Average Volume | 9,354 | ||
1-Week Change | 4.90% | ||
1-Month Change | -11.50% | ||
1-Year Change | -74.23% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 16.8M | ||
Total Assets | $4.7M | ||
Market Cap | $100.6M | ||
Enterprise Value | $101.1M | ||
Period: QTR TTM FY | |||
Revenue | -$98,387.00 | ||
Net Income | -$5.8M | ||
Free Cash Flow | -$3.0M | ||
EBIT | -$5.7M | ||
EBITDA | -$5.7M | ||
Net Working Capital | -$4.1M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | -1,028 | ||
P/B | N/A | ||
P/E | -4 | ||
PEG | -1 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 03/06/2026 | ||
Earnings & Revenue